Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

Improving the Quality of Care for Patients Harboring ALK+ NSCLC

7/1/2021

 
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
​
CME activity here: https://reachmd.com/programs/cme/improving-quality-care-patients-harboring-alk-nsclc/12631/

This CME activity will review molecular testing for ALK rearrangements, approved and emerging therapeutic options for the first-line treatment of ALK+ NSCLC and treatment upon disease progression, treatment selection and sequencing, and efficacy and safety data of ALK inhibitors.



Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates